FMC Stock News

NEW YORK , March 11, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FMC Corporation (NYSE: FMC) between November 16, 2023 and February 4, 2025, both dates inclusive (the "Class Period"), of the important April 14, 2025 lead plaintiff deadline. So what: If you purchased FMC securities during the Class Period you may be entitled to comp...

FMC Corporation offers a compelling entry point at a multi-year low with a historically high 5.6% yield, despite near-term headwinds. Its growth portfolio, including new active ingredients and biological products, is set to drive significant future revenue. FMC's cost-saving measures and deleveraging efforts have strengthened profitability and financial position, with analysts expecting a sharp...

BENSALEM, Pa. , March 10, 2025 /PRNewswire/ -- The Law Offices of Howard G.

“This is the 110th consecutive quarter we have increased our dividend since our 1994 NYSE listing and this declaration represents the 656th consecutive  monthly dividend throughout our 56-year operating history.

NEW YORK , March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of FMC Corporation (NYSE: FMC). Shareholders who purchased shares of FMC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

The top executives of Moderna, Akamai, and FMC just bought stock on the open market. All three shares are in the red for 2025 after a tough 2024.

LOS ANGELES , March 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to FMC Corporation ("FMC" or the "Company") (NYSE: FMC) have opportunity to lead the securities fraud class action lawsuit.

NEW YORK , March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of FMC Corporation (NYSE: FMC). Shareholders who purchased shares of FMC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.